Erste Asset Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $11.8M | Hold |
|
|||||
|
2023
Q1 | $7.12M | Hold |
|
|||||
|
2022
Q4 | $8.06M | Hold |
|
|||||
|
2022
Q3 | $6.05M | Sell |
|
|||||
|
2022
Q2 | $5.65M | Sell |
|
|||||
|
2022
Q1 | $5.66M | Buy |
|
|||||
|
2021
Q4 | $4.94M | Buy |
|
|||||
|
2021
Q3 | $3.33M | Buy |
|
|||||
|
2021
Q2 | $3.27M | Buy |
|
|||||
|
2021
Q1 | $3.21M | Buy |
|
|||||
|
2020
Q4 | $3.1M | Sell |
|
|||||
|
2020
Q3 | $2.5M | Buy |
|
|||||
|
2020
Q2 | $2.24M | Sell |
|
|||||
|
2020
Q1 | $3.12M | Sell |
|
|||||
|
2019
Q4 | $1.71M | Buy |
|
|||||
|
2019
Q3 | $1.37M | Buy |
|
|||||
|
2019
Q2 | $1.72M | Buy |
|
|||||
|
2019
Q1 | $3.64M | Buy |
|
|||||
|
2018
Q4 | $1.12M | Buy |
|